PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Phenotype | |liver cirrhosis |
| Sentences | 69 |
| PubMedID- 23423240 | Portal vein thrombosis (pvt) is commonly associated with liver cirrhosis, irrespective of the presence of hepatocellular carcinoma (hcc). |
| PubMedID- 23769105 | Liver transplantation (lt) is a life-saving treatment for liver cirrhosis patients with hepatocellular carcinoma (hcc). |
| PubMedID- 26166077 | Magnetic resonance spectroscopy was used as a means of predicting the probability of developing hepatocellular carcinoma (hcc) in patients with liver cirrhosis secondary to chronic hepatitis b.this study included 20 healthy volunteers, 20 patients with liver cirrhosis secondary to chronic hepatitis b (cirrhosis group), and 20 patients with small hcc secondary to cirrhosis liver parenchyma (hcc group). |
| PubMedID- 24965914 | Cumulative overall survival in hepatocellular carcinoma (hcc) patients with liver cirrhosis, tumor size within 3 cm and up to 3 nodules treated with radiofrequency ablation (rfa) (n = 179) and surgical resection (sr) (n = 179) after propensity score matching. |
| PubMedID- 20736226 | Left atrial metastasis from hepatocellular carcinoma with liver cirrhosis. |
| PubMedID- 23146511 | Introduction: the coexistence of liver cirrhosis with hepatocellular carcinoma (hcc) and colon cancer (ca), which is a rare clinical condition, was treated in a liver transplant recipient. |
| PubMedID- 23904843 | The greatest advantage of pure laparoscopic hepatectomy for hepatocellular carcinoma with concomitant liver cirrhosis is that postoperative ascites retention is minimal, meaning that there is little risk of water-electrolyte imbalance associated with ascites retention or hypoproteinemia. |
| PubMedID- 23732780 | Influence of etiology on host immunity in liver cirrhosis patients with advanced hepatocellular carcinoma receiving intra-arterial chemotherapy. |
| PubMedID- 20345561 | Liver transplantation for unresectable hepatocellular carcinoma in patients without liver cirrhosis. |
| PubMedID- 25785114 | Risk factors for naturally-occurring early-onset hepatocellular carcinoma in patients with hbv-associated liver cirrhosis in china. |
| PubMedID- 21695929 | Its efficacy was shown in the sharp study that enabled licensing of sorafenib for the therapy of inoperable, metastasizing hepatocellular carcinoma, including patients with liver cirrhosis, functional class child-pugh a or b, in more than 60 countries worldwide, including the czech republic. |
| PubMedID- 21377941 | Conclusions: contrast enhanced ultrasound has a high diagnostic value and reproducibility for non-invasive grading of hypervascular hepatocellular carcinoma >1cm in patients with liver cirrhosis. |
| PubMedID- 22208688 | Objective: liver transplantation (lt) is known to be a promising treatment for patients with liver cirrhosis associated with hepatocellular carcinoma (hcc). |
| PubMedID- 25891119 | The present study examined the prognostic ability of our proposed performance status combined japan integrated staging (ps-jis) system in hepatocellular carcinoma (hcc) patients with liver cirrhosis (lc) comparing with other four prognostic systems including original jis system, the barcelona clinic liver cancer classification system, tnm classification system and the cancer of the liver italian program (clip) scoring system. |
| PubMedID- 20087783 | Background: the antiangiogenic drug sorafenib has been shown to be an effective treatment for hepatocellular carcinoma (hcc) in patients with liver cirrhosis. |
| PubMedID- 19955816 | Impact of serial hepatitis b virus dna on hepatocellular carcinoma development in patients with liver cirrhosis. |
| PubMedID- 25852766 | Oldenlandia diffusa promotes antiproliferative and apoptotic effects in a rat hepatocellular carcinoma with liver cirrhosis. |
| PubMedID- 23708326 | Branched-chain amino acids (bcaas) reportedly inhibit the incidence of hepatocellular carcinoma (hcc) in patients with liver cirrhosis and obesity that is frequently associated with insulin resistance (ir). |
| PubMedID- 21286421 | A 49-year-old man (body weight: 86 kg, height: 169 cm) who was diagnosed as having hepatocellular carcinoma with liver cirrhosis due to hepatitis b virus (child-pugh grade c, meld score 14) presented for ldlt. |
Page: 1 2